U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185113) titled 'A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects' on Aug. 11.
Brief Summary: The goal of this clinical trial is to determine the pharmacokinetics (how the body interacts with administered substances for the entire duration of exposure) of Gen-1124 in an oral formulation (taken by mouth) in healthy volunteers. It will also learn about the safety of Gen-1124. The main questions it aims to answer are:
- How does Gen-1124 interact with a human body?
Researchers will look at how Gen-1124 interacts with the body and what side effects it may cause.
Participants will:
* Take Gen-1124 for a...